Dyadic International, Inc.
General ticker "DYAI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $37.0M (TTM average)
Dyadic International, Inc. does not follow the US Stock Market performance with the rate: -18.1%.
Estimated limits based on current volatility of 6.7%: low 0.89$, high 1.02$
Factors to consider:
- Total employees count: 7 as of 2023
- Top business risk factors: Operational and conduct risks, Regulatory and compliance, Economic downturns and volatility, Market competition, Cybersecurity threats
- Current price 17.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.21$, 2.73$]
- 2025-12-31 to 2026-12-31 estimated range: [1.04$, 2.43$]
Financial Metrics affecting the DYAI estimates:
- Positive: with PPE of -9.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -7.43 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 24.88 <= 41.86
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0.80 <= 3.41
Short-term DYAI quotes
Long-term DYAI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2.93MM | $2.90MM | $3.50MM |
| Operating Expenses | $13.10MM | $11.13MM | $9.40MM |
| Operating Income | $-10.17MM | $-8.23MM | $-5.90MM |
| Non-Operating Income | $0.43MM | $1.43MM | $0.09MM |
| Interest Expense | $0.00MM | $0.00MM | $0.43MM |
| R&D Expense | $4.50MM | $3.30MM | $2.04MM |
| Income(Loss) | $-9.74MM | $-6.80MM | $-5.81MM |
| Profit(Loss)* | $-9.74MM | $-6.80MM | $-5.81MM |
| Stockholders Equity | $11.09MM | $5.88MM | $2.47MM |
| Assets | $13.71MM | $8.22MM | $9.93MM |
| Operating Cash Flow | $-8.08MM | $-6.73MM | $-3.97MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-2.37MM | $7.45MM | $-1.88MM |
| Financing Cash Flow | $0.54MM | $0.00MM | $5.85MM |
| Earnings Per Share** | $-0.34 | $-0.24 | $-0.20 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.